Dr. Reddy's Laboratories Limited
RDY
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that areā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
25 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$13.03
Price-1.74%
-$0.23
1Y
Price
Market Cap
$10.848b
Large
Price/Earnings 3y Avg5y Avg
24.6x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in INR.+8.0%
EBITDA Margin+2.9%
Net Profit Margin+14.1%
Free Cash Flow Margin+8.0%
EBITDA Margin+2.9%
Net Profit Margin+14.1%
Free Cash Flow MarginRevenue
$353.472b
+3.6%
1y CAGR+11.2%
3y CAGR+12.1%
5y CAGREarnings
$45.087b
-24.2%
1y CAGR+0.3%
3y CAGR+23.0%
5y CAGREPS
$53.92
-24.0%
1y CAGR+0.2%
3y CAGR+23.0%
5y CAGRBook Value
$372.925b
$567.877b
Assets$194.952b
Liabilities$75.810b
DebtDebt to Assets
13.4%
1x
Debt to EBITDAFree Cash Flow
$32.102b
+101.6%
1y CAGR+4.5%
3y CAGR+88.8%
5y CAGRNo items found.
Press Releases
Statements and updates from the company